visibility, and rapid publication 1 (average of 3 months from acceptance to publication). Our papers are indexed in MEDLINE and Current Contents and have In the light of these and other comments we have decided to keep our current format for the next several been positively reviewed in other scientific journals, such as Science, The Lancet, Nature Genetics, and by volumes, making just a few small changes to adjust to our current editorial reality. the press. Our goal of integrating molecular medicine and clinical psychiatry has been fully achieved. As we
We are now receiving a very large number of outstanding papers. We have increased the number of start our third volume it is time to re-assess our format and to make adjustments in order to foster growth and pages available for original research articles, and we do encourage brevity to maximize the use of our space. We to continue to bring to our readers the best research in molecular psychiatry. As a field, molecular psychiatry strongly advise authors to use our more concise style B whenever possible. However, these measures alone is undergoing explosive growth, and there is a general feeling that fundamental molecular mechanisms for will not make it possible for us to publish a much larger number of the outstanding papers we are curpsychiatric disorders will soon be identified. Unfortunately, it is still true that the causes of all major psychirently receiving. In order to maintain our editorial policy of rapid publication we must by necessity reject atric disorders remain unknown. At this point rather than focus on the enormity of what we do not know, many of the excellent papers that arrive in the editorial office. To be able to effectively serve authors, we have it might be helpful to think of the title of Paul Gaugin's painting 'D'où venons-nous? Que sommes-nous? Où instituted a two-tier review process. Manuscripts are first rapidly examined by at least two members of the allons-nous?' (From where do we come? What are we? Where do we go?). Having rapidly gained the support editorial board. If we feel that, in the light of the quality of all manuscripts we are receiving, a specific paper and recognition from clinicians and researchers, we should examine where the journal is today, before cannot effectively compete for our limited space, we will send it back to the corresponding author, without attempting to address the perennially intractable question: 'Where do we go?' written comments. Those papers that go to formal peerreview will receive within 3 weeks written comments The general advice we have received from our editorial board and from our readers is not to make that will be sent back to authors. This will permit us to handle an increasingly large number of papers changes. ing. If they are found to be appropriate for that section of the content-the rest being a mixture of editorials, newsthey are fully reviewed within one week of receipt in and-views items, short reviews in the guise of perspectives or progress articles, meeting reports, a calendar, and sumour office, and published within 3-10 weeks of submaries of seminars or clinical grand rounds. This makes mission. This is the fastest outlet for publication in our for interesting reading and gives the busy scientist or clinfield; we predict that this section will be one of the E-mail ϽlicinioȰnih.govϾ for specific instructions.
